Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

813.33 +13.53 (+1.69%)
Official Closing Price Updated: 7:00 PM EST, Dec 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a $100B market. 
Via Benzinga
Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum
Defiance ETFs introduces NVOX, a leveraged ETF offering 2X exposure to Novo Nordisk's stock price movements, targeting the booming weight loss market with tactical trading opportunities. 
Via Benzinga
Topics ETFs
Eli Lilly Gap
I took on a bearish position on Eli Lilly (LLY​​​​​​​) today. I think the days of Big Pharma just printing up profits out of thin air are over. 
Via Talk Markets
Topics Stocks / Equities
It’s Been A Tough Month For Healthcare Stocks
It’s been a very difficult month for the healthcare sector not only because of disappointing company news but also disruption caused by the election and future policy issues. 
Via Talk Markets
Topics ETFs Stocks / Equities
Macy's Multimillion-Dollar Error
We also talk about snack foods, AI, Netflix's strategy on live events, and more. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Behind the Scenes of Eli Lilly's Latest Options Trends
Via Benzinga
Why Amgen's Weight Loss Result Is a Win for Eli Lilly
Via The Motley Fool
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
Pharma companies lobby for changes to Medicare drug price rules, targeting a four-year delay for pills' eligibility. Critics warn it may hinder patient access and innovation. 
Via Benzinga
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
A study finds that anti-obesity medications may help reduce alcohol consumption, with nearly half of participants in weight loss programs reporting decreased use. 
Via Benzinga
Prediction: This Unstoppable Vanguard ETF Will Beat the S&P 500 Again in 2025
This exchange-traded fund holds big positions in top-performing growth stocks like Nvidia. 
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
Via The Motley Fool
Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Program
Bristol Myers Squibb sues HRSA, claiming its rejection of a rebate model for 340B pricing violates federal law. The lawsuit highlights concerns over program abuse and regulatory overreach. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
(LLY) - Analyzing Eli Lilly's Short Interest
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Analysts are concerned about Viking's ability to compete in the lucrative obesity drug market, dominated by Eli Lilly and Novo Nordisk. 
Via Benzinga
Does Billionaire Israel Englander Know Something Wall Street Doesn't? The Billionaire Investor Just Sold 8.1 Million Shares of Walmart Stock.
Israel Englander's Millennium Management reduced its stake in Walmart by 69% last quarter. 
Via The Motley Fool
Stock Market Hits Highs Despite Trump Tariff Threats, Nvidia, Tech Turkeys: Weekly Review
The Nasdaq isn't at a high, but it isn't far off either. 
Via Investor's Business Daily
Topics Government
Exposures Political
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines. 
Via MarketBeat
Topics Government
Exposures COVID-19 Political Product Safety
Down More Than 20% From Its High, Is Now the Time to Buy Eli Lilly Stock?
Via The Motley Fool
LeapFrog Investments raises more than $1 billion for impact health investing
LeapFrog Investments said this week it has raised more than $1 billion in a new investment fund that targets high-impact health and financial-services 
Via Equities.com
The Ultimate Pharmaceutical Stock to Buy With $1,000 Right Now
Via The Motley Fool
Tradepulse Power Inflow Alert: Eli Lilly & Company Climbs Over 22 Points After Alert
Via Benzinga
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
The U.S. stock market traded mixed on Tuesday morning, with major indices showing tight movements as investors awaited the release of the Federal Reserve's November meeting minutes. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
The Biden Administration's proposal expands Medicare and Medicaid coverage for anti-obesity drugs, cutting costs for millions while addressing the obesity crisis. 
Via Benzinga
Eli Lilly Stock Is Rising Tuesday: What's Going On?
Eli Lilly And Co (NYSE:LLY) shares are trading higher Tuesday after the Biden-Harris Administration proposed a new rule to expand coverage of anti-obesity medications for Americans with Medicare and... 
Via Benzinga
Amgen Crashes 12% After Weight-Loss Drug Meets Eli Lilly's In A Key Test
Over the course of a year, Amgen's MariTide helped patients lose about 20% of their body weight. 
Via Investor's Business Daily
Thankful Investors - Last 5 Years
A look at the 25 best-performing stocks in the S&P 1500 on a total return basis over the last five years. 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
Via The Motley Fool
When It Is Too Late To Trade
Is it too late to get started with swing trading when considering the stock market rally, or should a new trader wait for a market crash or pullback? 
Via Talk Markets
Topics Stocks / Equities
Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.